Form 4: Victory Capital Director Acquires Stock in Lieu of Cash
Insider Transaction Report
Victory Capital Holdings Director Lawrence Davanzo acquired 435 shares of common stock on October 10, 2025, in lieu of cash director fees, aligning his interests with shareholders.
Summary
- Lawrence Davanzo, a Director of Victory Capital Holdings, Inc. (VCTR), acquired 435 shares of common stock.
- The transaction occurred on October 10, 2025, at a price of $65.98 per share.
- These shares were issued in lieu of quarterly director fees, which amounted to $28,750 in cash equivalent.
- Following this transaction, Mr. Davanzo directly beneficially owns 435 shares.
- Additionally, 190,812 shares are indirectly beneficially owned through the Lawrence E. Davanzo and Christine Davanzo Revocable Trust, for which Mr. Davanzo serves as trustee.
Sentiment
Score: 6
Explanation: Slightly positive, as the director's decision to take stock over cash indicates confidence in the company's future performance and aligns his interests with shareholders.
Positives
- The acquisition of shares by a director in lieu of cash compensation demonstrates alignment of management's interests with those of shareholders.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned and transparent approach to insider transactions.
Future Outlook
The filing does not contain any forward-looking statements or guidance.
Management Comments
- The issuance of common stock to Mr. Davanzo in lieu of cash for quarterly director fees reflects the company's compensation policy for its board members.
Industry Context
Compensating directors with equity, such as common stock, is a common practice across various industries. This method is often employed to align the interests of board members with those of the company's shareholders, encouraging long-term value creation.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation Policy | The company's policy allows for the issuance of common stock to directors in lieu of cash for quarterly fees, as demonstrated by this transaction. | 10/10/2025 | This policy aligns director incentives with shareholder interests by linking compensation directly to the company's stock performance. |
Related Party Transactions
- The acquisition of common stock by Director Lawrence Davanzo in lieu of cash director fees constitutes a related party transaction, as it involves compensation between the company and a member of its board.
Stakeholder Impact
- Shareholders: The issuance of new shares for director compensation results in a minor dilution, but the alignment of director interests with shareholders is generally viewed positively.
- Directors: Lawrence Davanzo's direct beneficial ownership increases, strengthening his financial stake in the company's performance.
Key Dates
| Date | Description |
|---|---|
| 10/10/2025 | Date of transaction where 435 shares of Common Stock were acquired. |
| 10/14/2025 | Date the Form 4 filing was signed. |
Recommendation
holdThis Form 4 filing details a routine insider transaction related to director compensation. While the director's choice to receive stock over cash can be seen as a positive signal of confidence and alignment, the transaction size (435 shares) is not significant enough to materially impact the company's valuation or warrant a change in investment recommendation based solely on this filing. It reinforces a 'hold' position, awaiting more substantial operational or financial news.
Keywords
Victory Capital Holdings, VCTR, Insider Trading, Form 4, Director Compensation, Stock Acquisition, Equity Compensation, Lawrence Davanzo
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.